Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Should you should talk to strangers? Doing so increases positive experience, study shows

  • Genetic dysfunction connected to hydrocephalus discovered by international research team

  • Good news for aging population: Incidence of stroke in elderly has dropped by 40% over last 20 years

  • You should talk to strangers: Doing so increases positive experience, study shows

  • High rates of violence suffered by unstably housed women in San Francisco

  • Mothers of Children with Autism Benefit From Peer-Led Intervention

  • Children's impulsive behaviour is related to brain connectivity

  • Innovative system anticipates driver fatigue in the vehicle to prevent accidents

  • Rigid connections: Molecular basis of age-related memory loss explained

  • Low strength brain stimulation may be effective for depression

  •